journal logo
  • search
  • open the menu

Intro Pullout Text Widget

Impact Factor: 3.437
Citescore: 4.0
All metrics >>

The International Journal of Gynecological Cancer (IJGC) is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. Its content is read by gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology. IJGC emphasizes a multidisciplinary approach and includes original research, reviews, and video articles.

IJGC is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

IJGC is a Plan S compliant Transformative Journal.

EDITOR-IN-CHIEF
Pedro Ramirez, MD, University of Texas MD Anderson Cancer Center
Editorial Board

Podcast iconListen to the IJGC weekly podcast. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.

Latest Content
International Journal of Gynecological Cancer

Highlighted Articles

Highlighted Articles

Twitter Feed

Authors

The International Journal of Gynecological Cancer accepts submissions of original research and reviews.

The Author Information section provides specific article requirements to help you turn your research into an article suitable for IJGC.

Information is also provided on editorial policy, Open Access fees and formatting.

IJGC Zoom Journal Club

IJGC Journal Club, November 2021

Join Editor-in-Chief Pedro Ramirez, Social Media Editor Ane Gerda Zahl Eriksson, and the IJGC Editorial Fellows in a lively and entertaining discussion over Zoom of the lead article in IJGC's November 2021 issue.

Announcing New Editorial Board Member

We are very proud to announce a new member of the Editorial Board Member, Dr. Ainhoa Madariaga. Dr. Madariaga is a medical oncologist at 12 de Octubre Hospital in Madrid, Spain. Her clinical and academic areas of interest are gynecologic cancers, drug development and patient-reported outcome assessment.

Podcasts